MariMed Inc (MRMD)
0.2551
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
MariMed Net Income (Quarterly): -1.298M for March 31, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -1.298M |
| December 31, 2023 | -10.17M |
| September 30, 2023 | -4.259M |
| June 30, 2023 | -0.958M |
| March 31, 2023 | -0.645M |
| December 31, 2022 | 4.751M |
| September 30, 2022 | 2.706M |
| June 30, 2022 | 1.823M |
| March 31, 2022 | 4.188M |
| December 31, 2021 | -6.508M |
| September 30, 2021 | 2.02M |
| June 30, 2021 | 7.493M |
| March 31, 2021 | 4.22M |
| December 31, 2020 | 4.121M |
| September 30, 2020 | 1.659M |
| June 30, 2020 | -1.214M |
| March 31, 2020 | -2.421M |
| December 31, 2019 | -78.44M |
| September 30, 2019 | -7.399M |
| June 30, 2019 | 4.677M |
| March 31, 2019 | -0.0232M |
| December 31, 2018 | -7.744M |
| September 30, 2018 | -3.503M |
| June 30, 2018 | -0.462M |
| March 31, 2018 | -1.895M |
| Date | Value |
|---|---|
| December 31, 2017 | -1.316M |
| September 30, 2017 | -0.3925M |
| June 30, 2017 | 0.547M |
| March 31, 2017 | -0.0322M |
| December 31, 2016 | 0.0113M |
| September 30, 2016 | -0.0608M |
| June 30, 2016 | -0.051M |
| March 31, 2016 | -0.1005M |
| December 31, 2015 | -0.552M |
| September 30, 2015 | -0.1182M |
| June 30, 2015 | -0.337M |
| March 31, 2015 | -0.2082M |
| December 31, 2014 | -3.517M |
| September 30, 2014 | -3.445M |
| June 30, 2014 | -0.1252M |
| March 31, 2014 | -0.132M |
| December 31, 2013 | -0.1523M |
| September 30, 2013 | -0.0855M |
| June 30, 2013 | -0.1254M |
| March 31, 2013 | -0.1725M |
| December 31, 2012 | -0.3833M |
| September 30, 2012 | -0.182M |
| June 30, 2012 | -0.1456M |
| March 31, 2012 | -0.0987M |
| September 30, 2011 | -0.0984M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-78.44M
Minimum
Dec 2019
7.493M
Maximum
Jun 2021
-3.783M
Average
0.5069M
Median
Net Income (Quarterly) Benchmarks
| Emergent BioSolutions Inc | 9.00M |
| Zymeworks Inc | -31.65M |
| Viemed Healthcare Inc | 1.603M |
| NovaBay Pharmaceuticals Inc | -3.214M |
| Palatin Technologies Inc | -7.844M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 37.93M |
| Total Expenses (Quarterly) | 35.83M |
| EPS Diluted (Quarterly) | -0.0035 |
| Enterprise Value | 148.43M |
| Gross Profit Margin (Quarterly) | 43.42% |
| Profit Margin (Quarterly) | -3.42% |
| Earnings Yield | -14.16% |
| Operating Earnings Yield | 12.69% |
| Normalized Earnings Yield | -4.951 |